6109-70-2
Chemical Structure
Aceclidine hydrochloride
Synonym(s): Quinuclidin-3-yl acetate hydrochloride
- CAS No.: 6109-70-2
- Formula:C9H16ClNO2
- Molecular Weight:205.68
IUPAC Name: (1s,4s)-quinuclidin-3-yl acetate hydrochloride
InChIKey: LWWSARSTZGNKGV-UHFFFAOYSA-N
SMILES: CC(OC1C[N@@]2CC[C@H]1CC2)=O.Cl
Biological Activity: Aceclidine (Quinuclidin-3-yl acetate) hydrochloride is a modulator of M3 muscarinic acetylcholine receptor and a M1 receptor agonist (EC50: 40 μM). Aceclidine hydrochloride is a cycloplegic agent, a surfactant, a tonicity adjustor and optionally a viscosity enhancer and an antioxidant. Aceclidine hydrochloride has the potential for the research of disorders such as refractive errors of the eye, xerostomia, Sjogren's syndrome, glaucoma, conjunctivitis, lacrimal gland disease, and esotropia[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Aceclidine hydrochloride | 98.0% | Aceclidine (Quinuclidin-3-yl acetate) hydrochloride is a modulator of M3 muscarinic acetylcholine receptor and a M1 receptor agonist (EC50: 40 μM). Aceclidine hydrochloride is a cycloplegic agent, a surfactant, a tonicity adjustor and optionally a viscosity enhancer and an antioxidant. Aceclidine hydrochloride has the potential for the research of disorders such as refractive errors of the eye, xerostomia, Sjogren's syndrome, glaucoma, conjunctivitis, lacrimal gland disease, and esotropia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Aceclidine-d3 hydrochloride | Aceclidine-d3 hydrochloride is a deuterated version of Aceclidine (HY-32067). Aceclidine is a modulator of the M3 muscarinic acetylcholine receptor. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Gerald Horn, et al. Storage Stable Compositions and Methods for the Treatment of Refractive Errors of the Eye. Patent US20150290125A1.
- [2]. Thomas G. Gant, et al. Imidazole modulators of muscarinic acetylcholine receptor m3. Patent US20110091459A1.
- [3]. Cui Y, et al. Enhancement of memory function in aged mice by a novel derivative of xanomeline. Cell Res. 2008 Nov;18(11):1151-3. [Content Brief]
